FDA Clearance Tracker · P210037-S002
Prospera SCS System Next Generation Active Anchor, TrueLock
Last checked: Nov 20, 2026Latest source record: Feb 15, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 15, 2024
Approved
Time to decision
205 days
Received Jul 25, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P210037-S002
- Device name
- Prospera SCS System Next Generation Active Anchor, TrueLock
- Applicant
- Biotronik Nro, Inc.
- Applicant location
- Lake Oswego, OR
- Received
- Jul 25, 2023
- Decided
- Feb 15, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P210037
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Prospera Spinal Cord Stimulation (SCS) System Next Generation Active Anchor, TrueLock. The Indications for Use (IFU) of the device is as follows:The Prospera spinal cord stimulation (SCS) system is indicated as an aid in the management of chronic, intractable pain in the trunk and/or limbs, which may include unilateral or bilateral pain, resulting from any of the following: 1) Failed Back Syndrome (FBS) or low back syndrome or failed back; 2) Radicular pain syndrome or radiculopathies resulting in pain secondary to FBS or; 3) herniated disk; 4) Post laminectomy pain; 5) Multiple back operations; 6) Unsuccessful disk surgery; 7) Degenerative Disk Disease (DDD)/herniated disk pain refractory to conservative and; 8) surgical interventions; 9) Peripheral causalgia;10) Epidural fibrosis;11) Arachnoiditis or lumbar adhesive arachnoiditis; and12) Complex Regional Pain Syndrome (CRPS), Reflex Sympathetic Dystrophy (RSD), or causalgia.
Source documents
Other decisions for Biotronik Nro, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P210037 · Decided Mar 31, 2023 · 484 days after receipt
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.